Wire Stories
-
456InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that the Center...
-
597Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd.
LUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in food testing and a global scientific leader in bioanalytical testing, announces...
-
515Disclosure of data on Agaricus blazei mushroom, KA21’s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku
TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data concerning the mechanism by which Agaricus blazei KA21 enhances immunity, its immunological...
-
445Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku
TOKYO–(BUSINESS WIRE)–On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning the effects of Agaricus blazei mushroom, KA21...
-
561Survey of degree of satisfaction with Agaricus blazei mushroom KA21 for promoting the health of senior dogs and cats among veterinarians and pet owners, Toei Shinyaku
Improvement of the appetite, coat & amount of fur, and amount of exercise among senior dogs and cats TOKYO–(BUSINESS WIRE)–A survey was...
-
513Toei Shinyaku Acquires Patent for Measurement Method of Beta-glucan, a Main Ingredient of Agaricus blazei mushroom
TOKYO–(BUSINESS WIRE)–Through its research on Agaricus blazei, KA21 strain, Toei Shinyaku has established a measurement method for beta-glucan, one of the main...
-
455Announcement of Agaricus blazei mushroom, KA21 strain�s Ability to Improve QOL of Athletes at Annual Meeting, Toei Shinyaku
Athlete performance, overall condition, quality of sleep, sense of fatigue, mental condition, concentration ability, muscle condition, stamina, and resilience. TOKYO–(BUSINESS WIRE)–Toei Shinyaku...
-
530ENHERTU� Approved in the U.S. as the First HER2 Directed Therapy for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Based on DESTINY-Lung02 results which showed Daiichi Sankyo and AstraZeneca�s ENHERTU reported a confirmed objective response rate of 57.7% in patients with...
-
502Study into the Satisfaction Level of Veterinarians Regarding the Effects of Agaricus blazei mushroom, KA21 supplement on Dogs / Cats Malassezia and Dermatophytosis, Toei Shinyaku
TOKYO–(BUSINESS WIRE)–Toei Shinyaku conducted a survey to determine the effectiveness and veterinarian satisfaction level of Agaricus blazei KA21 supplement on Malassezia and...
-
667Stonepeak to Acquire Portfolio of Globe Telecom Towers in the Philippines
Forms joint venture with a subsidiary of the largest private sector electric distribution utility company in the Philippines to pursue telecommunications towers...
